SINTX Technologies Inc. (NASDAQ: SINT) lost 8.4% after announcing that it is moving into the next phase of the relationship with O2TODAY. The company sold the first Flex SN-AP antipathogenic silicon nitride powder shipment to O2TODAY for incorporation into a new line of filters and masks.
O2TODAY announce limited-pre-orders for Flex SN-AP integrated mask
Dr. Sonny Bal, President, and CEO at SINTX Technologies said, “O2TODAY announced on its website today that it is taking limited pre-orders for masks and mask filters integrated with SINTX’s antipathogenic powder. We share the excitement at this development, and we’ve appreciated the opportunity to collaborate on the development of O2TODAY’s products over the past year.”
SINTX is the leading FleX SN-AP antipathogenic silicon nitride powder supplier to O2TODAY. O2TODAY uses the powder to develop make filters and facemasks developed during the cooperation the two companies signed in the wake of the pandemic. So far, the cooperation has yielded numerous molest including a two-year Technology Licensing Agreement for the use of SINTX’s tech in mask filters and face masks, product sales royalties, and commercial deals on silicon nitride sales.
SINTX’s Flex SN-AP powder has a wide range of applications in consumer products
Interestingly, SINTX has been working with other partners in developing a product using its FleX SN-AP powder. The company’s Flex SN-AP powder can quickly reach inactive a wide range of bacteria, molds, and viruses, including SARS-CoV, H1N1, and influenza. As a result, the powder can be integrated into most consumer products making the disease-causing microbes resistant. In addition, the company’s R&D team has expertise and knowledge of creating niche applications with the FleX SN-AP tech to enhance SINTX’s offerings.
The O2TODAY face mask and mask filters with silicon nitride will be available o July 6, 2021, on limited pre-orders.